DFX Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Borrower
S•••••
Healthcare & Pharmaceuticalsgroup grade Bon a schedule nowsponsor unattributed
What matters now
- 92¢ → 66¢consensus mark
Consensus mark 66¢ on cost, down from 92¢ a year ago, 71¢ last quarter.
Q2 2026 · The lenders' own valuations, the most direct read of what they expect to recover.
Derived1 of 1 lender' own marks, weighted by principal - $1.42Mprincipal outstanding
$1.42M principal held by 1 lender; matures Dec 2027.
Q2 2026 · Refinancing is due in 15 months at a 66¢ mark.
FactBDC schedules of investments, 30 Jun 2026; a sum of the BDCs' pieces, a lower bound
Mark path, consensus per quarter end
92¢ · 91¢ · 86¢ · 71¢ · 66¢Q2 2025 to Q2 2026
Principal held
at least $1.4M
sum of BDC pieces, a lower bound
Fair value
$937,314
66c on cost, debt pieces
Unfunded
Not disclosed
commitments not yet drawn
BDC lenders
1
1 on the latest quarter
Facilities
1
0 equity pieces beside them
Next maturity
Dec 22, 2027
$1.4M inside 24 months
On the tape since
Dec 31, 2022
latest Jun 30, 2026
Events
5
dated, non-routine
Lender marks
each lender's own fair value over cost at Jun 30, 2026, folded to one row per lender
| Lender | Exposure | Current mark | QoQ change |
|---|---|---|---|
| A•••• C••••• B•• I••• | $1.42M | 66¢ | -5 pts |
Every BDC piece · 1 position across 1 lenderlargest principal first, with instrument and rate
| BDC | Instrument | Principal | Fair value | Rate |
|---|---|---|---|---|
| A•••• C••••• B•• I••• | term loan first lien Investment T••• 1st L••• T••• L••• I•••• S+ S••••• 4.50% I••••••• R••• 8.23% A••••••••• D• | $1.4M | $937,314 66c | SOFR+450 bp |
Capital structure as the BDCs see it
latest quarter end Jun 30, 2026
| Facility | Held | On cost | Pricing | Maturity | BDCs |
|---|---|---|---|---|---|
| first lien term loan first lien | at least $1.4M | 66c | SOFR+450 bp | Dec 22, 2027 | 1 |
Through time
the borrower's pieces summed across BDCs, every quarter end
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Jun 30, 2026 | 1 | $1.4M | $937,314 | 66c | 0 |
| Mar 31, 2026 | 1 | $1.4M | $1.0M | 71c | 0 |
| Dec 31, 2025 | 1 | $1.4M | $1.2M | 86c | 0 |
| Sep 30, 2025 | 1 | $1.4M | $1.3M | 91c | 0 |
All 14 quartersShow fewer
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Jun 30, 2025 | 1 | $1.4M | $1.3M | 92c | 0 |
| Mar 31, 2025 | 1 | $1.4M | $1.3M | 88c | 0 |
| Dec 31, 2024 | 1 | $2.9M | $2.7M | 92c | 0 |
| Sep 30, 2024 | 1 | $1.4M | $1.3M | 92c | 0 |
| Jun 30, 2024 | 1 | $1.5M | $1.4M | 95c | 0 |
| Mar 31, 2024 | 1 | $1.5M | $1.4M | 95c | 0 |
| Dec 31, 2023 | 1 | $2.9M | $2.6M | 91c | 0 |
| Sep 30, 2023 | 1 | $1.5M | $1.3M | 91c | 0 |
| Jun 30, 2023 | 1 | $1.5M | $1.3M | 91c | 0 |
| Dec 31, 2022 | 1 | $1.5M | $1.3M | 92c | 0 |
What changed
- Maturity approachingDec 22, 2027
- Maturity approachingDec 22, 2027
- Marked down across lendersJun 30, 2026
- Marked down (one lender)Jun 30, 2026
- Marked down across lendersMar 31, 2026
Full timeline · 8 eventsShow fewer
- Marked down (one lender)Mar 31, 2026
- Marked down across lendersDec 31, 2025
- Marked down (one lender)Dec 31, 2025
Sponsor
No sponsor attribution: no portfolio page, deal announcement or Form D signer consensus names an owner for this borrower group.
Identity
- Group key
- SYMPLRderivedthe codename stem after legal suffixes and deal words
- Spellings
- 1 across 1 BDCderived
- Industry
- Healthcare & Pharmaceuticalsreportedas one filer wrote it